Literature DB >> 24863848

Lucio's phenomenon: report of five cases.

Pablo Finucci Curi1, Julieta Solis Villaroel2, Nora Migliore3, Adriana Albertengo4, María Laura Aquino5, Federico Ceccato1, Sergio Paira6.   

Abstract

The different clinical forms of leprosy are mainly related to the variety of immunological responses to the infection. Several forms of lepromatous leprosy are recognized, including macular, nodular, and diffuse. Lucio's phenomenon is a rare but distinctive skin eruption seen in patients with diffuse lepromatous leprosy. The diffuse lesions of Lucio's phenomenon have a predilection for the extremities, can include nodules, and heal with atrophic stellate scars; histologically, a necrotizing vasculitis accompanied by a nonspecific inflammatory reaction may be seen. Because of its rarity and similarity with some manifestations of the rheumatic disease and other causes of vasculitis, Lucio's phenomenon may not be easily recognized, especially in non-endemic countries, which leads to confusing diagnosis and loss of time for treatment. We report five patients with vasculitis caused by Lucio's phenomenon.

Entities:  

Keywords:  Leprosy; Lucio’s phenomenon; Rheumatic manifestations; Vasculitis

Mesh:

Year:  2014        PMID: 24863848     DOI: 10.1007/s10067-014-2683-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

1.  Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico.

Authors:  María G Zavala-Cerna; Mary Fafutis-Morris; Cecilia Guillen-Vargas; Mario Salazar-Páramo; Diana E García-Cruz; Carlos Riebeling; Arnulfo Nava
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

Review 2.  Lucio phenomenon and Lucio leprosy.

Authors:  C Kaur; G P Thami; H Mohan
Journal:  Clin Exp Dermatol       Date:  2005-09       Impact factor: 3.470

Review 3.  Rheumatic manifestations of leprosy: clinical aspects.

Authors:  J C Pernambuco; W Cossermelli-Messina
Journal:  J Rheumatol       Date:  1993-05       Impact factor: 4.666

4.  The lepra reaction with necrotizing skin lesions. A report of six cases.

Authors:  S L Moschella
Journal:  Arch Dermatol       Date:  1967-06

5.  Lucio's Phenomenon: Report of Two Cases and Review of the Literature.

Authors:  S Roverano; S Paira; F Somma
Journal:  J Clin Rheumatol       Date:  2000-08       Impact factor: 3.517

6.  Diffuse leprosy of Lucio and Latapí: a histologic study.

Authors:  Francisco Vargas-Ocampo
Journal:  Lepr Rev       Date:  2007-09       Impact factor: 0.537

7.  Study of rheumatic manifestations and serologic abnormalities in patients with lepromatous leprosy.

Authors:  M Chavez-Legaspi; A Gomez-Vazquez; I García-De La Torre
Journal:  J Rheumatol       Date:  1985-08       Impact factor: 4.666

8.  Lucio's phenomenon is a necrotizing panvasculitis: mostly a medium-sized granulomatous arteritis.

Authors:  Mario Magaña; Jorge Fernández-Díez; Mario L Magaña
Journal:  Am J Dermatopathol       Date:  2008-12       Impact factor: 1.533

9.  Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease.

Authors:  S Loizou; S Singh; E Wypkema; R A Asherson
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 10.  Erythema nodosum leprosum: reactional leprosy.

Authors:  Jesús Cuevas; José Luis Rodríguez-Peralto; Rosario Carrillo; Félix Contreras
Journal:  Semin Cutan Med Surg       Date:  2007-06
View more
  2 in total

1.  Lucio phenomenon in a patient of lepromatous leprosy from India.

Authors:  Maninder Kaur; Suman Patra; Dinesh P Asati; Tanya Sharma; Shubhra Prasad
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

2.  Lepra reaction with lucio phenomenon mimicking cutaneous vasculitis.

Authors:  Durga Prasanna Misra; Jyoti Ranjan Parida; Abhra Chandra Chowdhury; Krushna Chandra Pani; Niraj Kumari; Narendra Krishnani; Vikas Agarwal
Journal:  Case Reports Immunol       Date:  2014-12-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.